Table 1.
Demographics of Delphi participants
| Round 1 (N = 470) | Round 2 (N = 336) | |
|---|---|---|
| Rolea | ||
|
Surgeona Medical Oncologist Radiation Oncologistc Otherd |
206 (43.8) 144 (30.6) 98 (20.8) 22 (4.7) |
153 (45.5) 90 (26.8) 77 (22.9) 16 (4.8) |
| Age | ||
|
<30 30-39 40-49 50-59 60 or over Prefer not to say/not reported |
5 (1.1) 96 (20.4) 158 (33.6) 146 (31.1) 56 (11.9) 9 (1.9) |
4 (1.2) 69 (20.5) 118 (35.1) 99 (29.5) 39 (11.6) 7 (2.1) |
| Geographical location of practice | ||
|
Europe Asia North America South America Australia/New Zealand Middle East Africa |
274 (58.3) 60 (12.8) 46 (9.8) 38 (8.1) 32 (6.8) 14 (3.0) 6 (1.3) |
209 (62.2) 45 (13.4) 30 (8.9) 19 (5.7) 20 (6.0) 9 (2.7) 4 (1.2) |
| Gender | ||
|
Female Male Prefer not to say/not reported |
248 (55.8) 213 (45.2) 9 (1.9) |
173 (51.5) 155 (46.1) 8 (2.4) |
| Years of experience at Consultant/Attending level | ||
|
< 5 years 5–10 years >10 years Prefer not to say/ not reported |
64 (13.6) 94 (20.0) 307 (65.3) 5 (1.1) |
47 (14.0) 69 (20.5) 216 (64.3) 4 (1.2) |
| Main type of practice | ||
|
Academic/University/Teaching Hospital Public Hospital Private Hospital Other |
338 (71.9) 58 (12.3) 56 (11.9) 18 (3.8) |
246 (73.2) 38 (11.3) 40 (11.9) 12 (3.6) |
| Research activee | 437 (93.0) | 316 (94.1) |
aIf more than one role stated, respondents were classified according to involvement in locoregional breast cancer treatments.
b13 surgeons also prescribed chemotherapy.
cIncludes 1 Consultant Therapeutic Radiographer (RTT) and 18 respondents who prescribed chemotherapy and gave radiation therapy.
dRadiologist n = 4; pathologist n = 2; non-clinical role n = 6, not stated = 3.
eDefined broadly as designing, leading or recruiting to clinical trials or other research studies.